Canada markets open in 1 hour 20 minutes

Hanall Biopharma Co., Ltd. (009420.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
33,950.00-250.00 (-0.73%)
At close: 03:30PM KST
Currency in KRW

Valuation Measures4

Market Cap (intraday) 1.73T
Enterprise Value 1.68T
Trailing P/E 495.65
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.89
Price/Book (mrq)9.31
Enterprise Value/Revenue 12.44
Enterprise Value/EBITDA 257.72

Trading Information

Stock Price History

Beta (5Y Monthly) 0.87
52-Week Change 359.07%
S&P500 52-Week Change 326.43%
52 Week High 346,750.00
52 Week Low 318,400.00
50-Day Moving Average 335,753.00
200-Day Moving Average 332,951.25

Share Statistics

Avg Vol (3 month) 3590.53k
Avg Vol (10 day) 3242.85k
Shares Outstanding 550.7M
Implied Shares Outstanding 651.34M
Float 834.5M
% Held by Insiders 138.31%
% Held by Institutions 118.91%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 210:1
Last Split Date 3May 03, 2006

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 2.60%
Operating Margin (ttm)-13.93%

Management Effectiveness

Return on Assets (ttm)0.48%
Return on Equity (ttm)1.98%

Income Statement

Revenue (ttm)134.91B
Revenue Per Share (ttm)2,661.36
Quarterly Revenue Growth (yoy)5.30%
Gross Profit (ttm)N/A
EBITDA 4.99B
Net Income Avi to Common (ttm)3.51B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)56.5B
Total Cash Per Share (mrq)1,114.49
Total Debt (mrq)1.29B
Total Debt/Equity (mrq)0.69%
Current Ratio (mrq)3.02
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)29.64B
Levered Free Cash Flow (ttm)4.85B